Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Depreciation and Depletion: 2014-2025

Historic Depreciation and Depletion for ProPhase Labs (PRPH) over the last 6 years, with Sep 2025 value amounting to $400,000.

  • ProPhase Labs' Depreciation and Depletion fell 78.95% to $400,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year decrease of 12.57%. This contributed to the annual value of $4.2 million for FY2024, which is 35.48% up from last year.
  • ProPhase Labs' Depreciation and Depletion amounted to $400,000 in Q3 2025, which was down 50.00% from $800,000 recorded in Q2 2025.
  • In the past 5 years, ProPhase Labs' Depreciation and Depletion ranged from a high of $1.9 million in Q3 2024 and a low of $400,000 during Q4 2024.
  • In the last 2 years, ProPhase Labs' Depreciation and Depletion had a median value of $800,000 in 2025 and averaged $880,000.
  • In the last 5 years, ProPhase Labs' Depreciation and Depletion spiked by 459.30% in 2021 and then tumbled by 78.95% in 2025.
  • Over the past 4 years, ProPhase Labs' Depreciation and Depletion (Quarterly) stood at $519,000 in 2021, then grew by 27.75% to $663,000 in 2022, then reached $400,000 in 2024, then tumbled by 78.95% to $400,000 in 2025.
  • Its Depreciation and Depletion was $400,000 in Q3 2025, compared to $800,000 in Q2 2025 and $400,000 in Q4 2024.